الولايات المتحدة · منصات وبيانات · The Motley Fool

Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy?

نشره The Motley Fool · الولايات المتحدة منذ 1 س

Both of these biotech stocks could be appealing to income investors.

اقرأ المقال كاملًا على The Motley Fool سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.fool.com)

يستحق القراءة أيضًا

Titan Investment Management LLC Makes New $4.43 Million Investment in Eli Lilly and Company $LLY

Saudi Arabia intercepts drones and missiles as fighting with Yemen’s Houthis continues

A $30,000 CD sat untouched for 25 years — now the bank says it has no record of the account

Musk says Ukraine violated Starlink terms with offensive drone strikes

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Gold prices break $4,000 as investors brace for crucial test